CNA Diagnostics Inc. has closed a new round of financing, raising $#SUBSCRIBERS ONLY CONTENT – where and how did you get your news? Subscribe today to see our research on this and all other subscriber ONLY news. Be informed!#
Calgary based CNA Diagnostics Inc. (CNAD) is a Molecular Diagnostics company developing disruptive diagnostic tests for a wide spectrum of complex diseases affecting people, pets and production animals. The company plans to commercialize high-sensitivity and specificity, molecular diagnostic technologies for subclinical detection of major diseases of food producing animals, companion animal and humans.
In June 2017, CNA Diagnostics and its German partners Metabion GmbH and Becker & Hickl GmbH were awarded CDN $800,000 from the Alberta and German governments to pursue development of a high throughput, rapid testing diagnostic machine.
photo credit: CNA Diagnostics Inc.
Latest posts by Ted Liu (see all)
- SPUD secures $11M new funding led by CIC - December 13, 2018
- Robotiq secures $31M growth equity financing from Battery Ventures - December 11, 2018
- OnDeck to acquire Seer Capital backed Evolocity Financial Group - December 5, 2018